Home » Animal Biotech Shop MetaMorphix Selling Assets

Animal Biotech Shop MetaMorphix Selling Assets

Feb 04, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Animal biotechnology firm MetaMorphix today announced the sale of its assets as part of its Chapter 11 bankruptcy filing.

The sale is for both its businesses, one directed at animal genomics, the other at growth and differentiation factors. American MedTech Advisors is advising the Calverton, MD.-based firm on the sale.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Dalí DNA Collected

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Synthetic-Conservation Biology Disconnect

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

This Week in Science

In Science this week: full CRISPR locus integration complex structure, and more.

What's Popular?

In Business News

  1. Danaher Q2 Revenues Grow 6 Percent; MDx Product Line Shut Down

  2. China's Direct Genomics Demonstrates Single-Molecule Sequencing of E. Coli

    Premium

  3. Courtagen Closes Genetic Testing Business, Citing Regulatory, Reimbursement Challenges

  4. Startup SpinDiag Raises €1.6M in Seed Funding

  5. Boreal Genomics Develops Method to Increase Accuracy, Reduce Cost of Liquid Biopsy

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.